<!doctype html>
 <html>
 <head>
 <meta charset='UTF-8'>
 <title>Bio</title>
 <style type='text/css'>
 	.in-bio-photo{
     width: 200px;
     height: 200px;
     border-radius: 100%;
     text-align: center;
 }	
 </style>
 </head>
  <body>
 <p style='text-align: center'><img class='in-bio-photo' src='/dtm/bios/2022/shah.jpg' alt='speaker-headshot'/></p><p style='text-align: center; font-weight: bold;'>Viral N. Shah, MD<br/>Barbara Davis Center for Diabetes, University of Colorado, Aurora, Colorado</p><p>
 Dr. Shah is an Associate Professor at the Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus. His research is focused on improving glycemic control and reducing complications, with special interest in fracture prevention, in people with type 1 diabetes.</p><p>Dr. Shah has been the PI for many clinical trials of diabetes technologies and therapeutics. Dr. Shah has served on many leadership positions. He is currently serving as Chair-Elect for the Diabetes Technology Interest Group at the ADA and a writing committee member for the American College of Endocrinology Self-Assessment Program writing committee member (2020-2022). He is a recipient of prestigious AACE Rising Start in Endocrinology award (2021).<br/>He serves as the Editor-in-Chief for Clinical Diabetology and Senior Editor for the Endocrine Connections. He is well published with over 120 research publications including original article, invited reviews, editorials, and book chapters.</p>
 </body>
 </html>